Search Results - "Tietze, Julia K."

Correlation of Baseline Tumor Burden with Clinical Outcome in Melanoma Patients Treated with Ipilimumab by Angelova-Toshkina, Daniela, Weide, Benjamin, Tietze, Lutz F, Hebst, Michelle, Tietze, Julia K

“…Tumor burden is a frequently mentioned parameter; however, a commonly accepted definition is still lacking. In this double-center prospective and retrospective…”
Get more information

CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis by Gerdes, Lisa Ann, Held, Kathrin, Beltrán, Eduardo, Berking, Carola, Prinz, Jörg C., Junker, Andreas, Tietze, Julia K., Ertl-Wagner, Birgit, Straube, Andreas, Kümpfel, Tania, Dornmair, Klaus, Hohlfeld, Reinhard

“…We investigated a patient who developed multiple sclerosis (MS) during treatment with the CTLA4‐blocking antibody ipilimumab for metastatic melanoma. Initially…”
Get full text

Evaluation of the heat sensitivity of Trichophyton rubrum and Trichophyton interdigitale by Seidel, Katharina, Tietze, Lutz F., Braun, Christian, Mann, Miriam, Kerschnitzki, Anette, Tietze, Julia K.

“…Background Onychomycosis affects up to 50% of patients in the older population. Objectives This study aimed to explore heat sensitivity of Trichophyton rubrum…”
Get full text

Linear and Volumetric Evaluation of the Adrenal Gland—MDCT-Based Measurements of the Adrenals by Schneller, Julia, Reiser, Maximilian, MD, Beuschlein, Felix, MD, Osswald, Andrea, MD, Pallauf, Anna, MD, Riester, Anna, MD, Tietze, Julia K., MD, Reincke, Martin, MD, Degenhart, Christoph, MD

“…Rationale and Objectives The purpose of this study was to provide normal values of volumetry and linear dimensions of adrenal glands. Materials and Methods…”
Get full text

Characterization of mouse CD4 T cell subsets defined by expression of KLRG1 by Beyersdorf, Niklas, Ding, Xin, Tietze, Julia K, Hanke, Thomas

“…The mouse killer cell lectin-like receptor G1 (KLRG1) is an inhibitory receptor known to be expressed on a subset of NK cells and antigen-experienced CD8 T…”
Get full text

Patient-Orientated Evaluation of Treatment of Non-Melanoma Skin Cancer with Rhenium-188 Compared to Surgery by Krönert, Maila I C, Schwarzenböck, Sarah M, Kurth, Jens, Heuschkel, Martin, Krause, Bernd J, Emmert, Steffen, Tietze, Julia K

“…Non-melanoma skin cancers (NMSCs) are responsible for up to one-third of all human malignancies. Surgery is usually the treatment of choice, but patients often…”
Get full text

Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help by Monjazeb, Arta M, Tietze, Julia K, Grossenbacher, Steven K, Hsiao, Hui-Hua, Zamora, Anthony E, Mirsoian, Annie, Koehn, Brent, Blazar, Bruce R, Weiss, Jonathan M, Wiltrout, Robert H, Sckisel, Gail D, Murphy, William J

“…We have previously demonstrated that immunotherapy combining agonistic anti-CD40 and IL-2 (IT) results in synergistic anti-tumor effects. IT induces expansion…”
Get full text

Combination therapy of melanoma using kinase inhibitors by Heppt, Markus V, Tietze, Julia K, Graf, Saskia A, Berking, Carola

“…PURPOSE OF REVIEWTreatment options for metastatic melanoma depend on the clinical course of the disease and the molecular profile such as mutations of the BRAF…”
Get full text

Dynamic Effective Elasticity of Melanoma Cells under Shear and Elongational Flow Confirms Estimation from Force Spectroscopy by Jötten, Anna Martina, Neidinger, Simon V., Tietze, Julia K., Welzel, Julia, Westerhausen, Christoph

“…The detection and enrichment of circulating melanoma cells is a challenge, as the cells are very heterogeneous in terms of their biomechanical properties and…”
Get full text

Late administration of murine CTLA-4 blockade prolongs CD8-mediated anti-tumor effects following stimulatory cancer immunotherapy by Sckisel, Gail D., Mirsoian, Annie, Bouchlaka, Myriam N., Tietze, Julia K., Chen, Mingyi, Blazar, Bruce R., Murphy, William J.

“…We have demonstrated that immunostimulatory therapies such as interleukin-2 (IL-2) and anti-CD40 (αCD40) can be combined to deliver synergistic anti-tumor…”
Get full text

Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions by Hassel, Jessica C, Heinzerling, Lucie, Aberle, Jens, Bähr, Oliver, Eigentler, Thomas K, Grimm, Marc-Oliver, Grünwald, Victor, Leipe, Jan, Reinmuth, Niels, Tietze, Julia K, Trojan, Jörg, Zimmer, Lisa, Gutzmer, Ralf

“…Graphical abstract…”
Get full text

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy by Hofmann, Lars, Forschner, Andrea, Loquai, Carmen, Goldinger, Simone M, Zimmer, Lisa, Ugurel, Selma, Schmidgen, Maria I, Gutzmer, Ralf, Utikal, Jochen S, Göppner, Daniela, Hassel, Jessica C, Meier, Friedegund, Tietze, Julia K, Thomas, Ioannis, Weishaupt, Carsten, Leverkus, Martin, Wahl, Renate, Dietrich, Ursula, Garbe, Claus, Kirchberger, Michael C, Eigentler, Thomas, Berking, Carola, Gesierich, Anja, Krackhardt, Angela M, Schadendorf, Dirk, Schuler, Gerold, Dummer, Reinhard, Heinzerling, Lucie M

“…Abstract Background Anti-programmed cell death receptor-1 (PD-1) antibodies represent an effective treatment option for metastatic melanoma as well as for…”
Get full text

Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy by Zimmer, Lisa, Goldinger, Simone M, Hofmann, Lars, Loquai, Carmen, Ugurel, Selma, Thomas, Ioannis, Schmidgen, Maria I, Gutzmer, Ralf, Utikal, Jochen S, Göppner, Daniela, Hassel, Jessica C, Meier, Friedegund, Tietze, Julia K, Forschner, Andrea, Weishaupt, Carsten, Leverkus, Martin, Wahl, Renate, Dietrich, Ursula, Garbe, Claus, Kirchberger, Michael C, Eigentler, Thomas, Berking, Carola, Gesierich, Anja, Krackhardt, Angela M, Schadendorf, Dirk, Schuler, Gerold, Dummer, Reinhard, Heinzerling, Lucie M

“…Abstract Background Anti-programmed cell death 1 (PD-1) antibodies represent an effective treatment option for metastatic melanoma and other cancer entities…”
Get full text

The proportion of circulating CD45RO+ CD8+ memory T cells is correlated with clinical response in melanoma patients treated with ipilimumab by Tietze, Julia K, Angelova, Daniela, Heppt, Markus V, Reinholz, Markus, Murphy, William J, Spannagl, Michael, Ruzicka, Thomas, Berking, Carola

“…Abstract Background Immune checkpoint blockade (ICB) has been a breakthrough in the treatment of metastatic melanoma. But with only about 20–40% long-term…”
Get full text

Higher intraoperative detection rate of suspicious non‐palpable lesions using wire marking in skin cancer patients by Tietze, Julia K., Emmert, Steffen, Troitzsch, Paulina, Rode, Susen

“…Summary Background Follow‐up protocols in patients after complete resection of high‐risk cutaneous tumors lead to a discovery of metastases in very early…”
Get full text

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition by Heppt, Markus V., Heinzerling, Lucie, Kähler, Katharina C., Forschner, Andrea, Kirchberger, Michael C., Loquai, Carmen, Meissner, Markus, Meier, Friedegund, Terheyden, Patrick, Schell, Beatrice, Herbst, Rudolf, Göppner, Daniela, Kiecker, Felix, Rafei-Shamsabadi, David, Haferkamp, Sebastian, Huber, Margit A., Utikal, Jochen, Ziemer, Mirjana, Bumeder, Irmgard, Pfeiffer, Christiane, Schäd, Susanne G., Schmid-Tannwald, Christoph, Tietze, Julia K., Eigentler, Thomas K., Berking, Carola

“…Uveal melanoma (UM) is an ocular malignancy with high potential for metastatic spread. In contrast to cutaneous melanoma, immunotherapy has not yet shown…”
Get full text

Prevalence of pathological skin-picking in dermatological patients by Spitzer, Carsten, Lübke, Laura, Lindstädt, Tereza, Gallinat, Christina, Tietze, Julia K., Emmert, Steffen, Thiem, Alexander

“…The prevalence of pathological skin-picking (PSP) has predominantly been studied in students and the community, but not yet in dermatological patients…”
Get full text

Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma by Heppt, Markus V, Roesch, Alexander, Weide, Benjamin, Gutzmer, Ralf, Meier, Friedegund, Loquai, Carmen, Kähler, Katharina C, Gesierich, Anja, Meissner, Markus, von Bubnoff, Dagmar, Göppner, Daniela, Schlaak, Max, Pföhler, Claudia, Utikal, Jochen, Heinzerling, Lucie, Cosgarea, Ioana, Engel, Jutta, Eckel, Renate, Martens, Alexander, Mirlach, Laura, Satzger, Imke, Schubert-Fritschle, Gabriele, Tietze, Julia K, Berking, Carola

“…Abstract Background Mucosal melanoma (MM) is a rare but diverse cancer entity. Prognostic factors are not well established for Caucasians with MM. Patients and…”
Get full text

Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors by Ruf, Theresa, Kramer, Rafaela, Forschner, Andrea, Leiter, Ulrike, Meier, Friedegund, Reinhardt, Lydia, Dücker, Pia, Ertl, Carolin, Tomsitz, Dirk, Tietze, Julia K., Gutzmer, Ralf, Dabrowski, Evelyn, Zimmer, Lisa, Gesierich, Anja, Zierold, Sarah, French, Lars E., Eigentler, Thomas, Amaral, Teresa, Heinzerling, Lucie

“…Immune checkpoint inhibitors (ICI) induce adverse events (irAEs) that do not respond to steroids, i.e. steroid-refractory (sr) irAEs, and irAEs in which…”
Get full text

Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis by Heppt, Markus V., Eigentler, Thomas K., Kähler, Katharina C., Herbst, Rudolf A., Göppner, Daniela, Gambichler, Thilo, Ulrich, Jens, Dippel, Edgar, Loquai, Carmen, Schell, Beatrice, Schilling, Bastian, Schäd, Susanne G., Schultz, Erwin S., Matheis, Fanny, Tietze, Julia K., Berking, Carola

“…Growing evidence suggests that concurrent loco-regional and systemic treatment modalities may lead to synergistic anti-tumor effects in advanced melanoma. In…”
Get full text